Edward Tuddenham
University College London
H-index: 87
Europe-United Kingdom
Top articles of Edward Tuddenham
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
The complex, confusing and poorly understood immune responses to AAV‐mediated gene transfer in haemophilia—Is more or less immunosuppression required? | Edward GD Tuddenham Graham R Foster | 2024/4 | |
Mathematical models of coagulation-Are we there yet? | Matt J Owen Joy R Wright Edward GD Tuddenham John R King Alison H Goodall | 2024/3/21 | |
Recent patents relating to generating transgenic animals, tissues and cells for xenotransplantation. | nature biotechnology | P Holzer RL Monroy A Ptitsyn E Chang J Adkins | 2024/1 |
Stable therapeutic transgenic FIX levels for more than 10 years in subjects with severe hemophilia B who received scAAV2/8-LP1-hFIXco adeno-associated virus gene therapy | Blood | Ulrike M Reiss Andrew M Davidoff Edward GD Tuddenham Pratima Chowdary Jenny H McIntosh | 2023/11/28 |
Long-Term Persistence of Antibodies to Adeno-Associated Viral Vectors Following Gene Therapy with scAAV8-LP1-Fixco | Blood | Jenny H McIntosh Saira Mohamed Lydia Ireland Christopher L Morton Ulrike M Reiss | 2023/11/28 |
Factor VIII Sequences | 2023/8/3 | ||
Prophylactic Treatment of Severe Haemophilia a Patients with Inhibitors to FVIII with Peglip-FVIII | Blood | Edward Tuddenham Richard Wolf-Garraway Gavin Ling | 2022/11/15 |
The Use of a Pegylated Liposome in a Phase II Trial to Enhance the Potency and Extend the Dosing Interval of Prophylactic Standard Half-Life FVIII, without Increasing the Dose | Blood | Edward Tuddenham Gavin Ling Richard Wolf-Garraway | 2022/11/15 |
Adeno-Associated Virus Factor VIII Vectors | 2022/10/27 | ||
Phase 1–2 trial of AAVS3 gene therapy in patients with hemophilia B | New England Journal of Medicine | Pratima Chowdary Susan Shapiro Mike Makris Gillian Evans Sara Boyce | 2022/7/21 |
Optimised Coding Sequence and Promoter | 2021/1/7 | ||
Prophylactic Treatment of Severe Haemophilia Á Patients with Inhibitors to FVIII with Peglip-FVIII | Blood | Margarita Timofeeva Nadezhda I Zozulya Tatiana Pospelova Marina V Kosinova Igor Kurtov | 2021/11/23 |
How do I counsel parents of a newly diagnosed boy with Haemophilia a? | Karin Kurnik Christoph Bidlingmaier Martin Olivieri | 2020/2 | |
Global coagulation assays in hemophilia A: a comparison to conventional assays | Research and Practice in Thrombosis and Haemostasis | Saman Aghighi Anne Riddell Christine A Lee Simon A Brown Edward Tuddenham | 2020/2/1 |
Haemophilia, the journey in search of a cure. 1960–2020 | British Journal of Haematology | Amit C Nathwani Edward GD Tuddenham | 2020/11 |
Late-breaking and COVID-19 oral communication session abstracts | Res Pract Thromb Haemost. 2020| 4 (Suppl. 2): 1–25 | PP Chowdary S Shapiro M Makris G Evans S Boyce | 2020 |
Method of treating hemophilia A | 2020/10/6 | ||
Factor VIII: the protein, cloning its gene, synthetic factor and now–35 years later–gene therapy; what happened in between? | Gavin Ling Edward GD Tuddenham | 2020/5 | |
Synergistic effect of bypassing agents and sequence identical analogue of emicizumab and fibrin clot structure in the in vitro model of hemophilia A | TH Open | Yanan Zong Aleksandra Antovic Nida Mahmoud Hourani Soutari Jovan Antovic Iva Pruner | 2020/4 |
